GIORGIONI, Gianfabio
 Distribuzione geografica
Continente #
NA - Nord America 11.472
EU - Europa 4.950
AS - Asia 4.318
SA - Sud America 490
AF - Africa 189
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 13
Totale 21.461
Nazione #
US - Stati Uniti d'America 11.091
CN - Cina 1.698
SG - Singapore 1.300
RU - Federazione Russa 1.199
IT - Italia 1.043
DE - Germania 662
BR - Brasile 406
VN - Vietnam 377
HK - Hong Kong 338
GB - Regno Unito 331
CA - Canada 311
SE - Svezia 301
UA - Ucraina 293
PL - Polonia 268
FR - Francia 259
FI - Finlandia 237
ZA - Sudafrica 140
KR - Corea 118
TR - Turchia 118
IE - Irlanda 85
BD - Bangladesh 75
IN - India 71
JP - Giappone 55
CZ - Repubblica Ceca 53
NL - Olanda 53
MX - Messico 45
BE - Belgio 44
ES - Italia 34
AR - Argentina 26
AU - Australia 26
IQ - Iraq 23
PK - Pakistan 20
UZ - Uzbekistan 17
EG - Egitto 15
HR - Croazia 14
IR - Iran 14
PE - Perù 14
AT - Austria 13
EU - Europa 13
EC - Ecuador 12
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
ID - Indonesia 10
LT - Lituania 10
SA - Arabia Saudita 10
MA - Marocco 9
AZ - Azerbaigian 8
CO - Colombia 8
MY - Malesia 8
UY - Uruguay 8
KE - Kenya 7
PT - Portogallo 7
KG - Kirghizistan 6
TH - Thailandia 6
VE - Venezuela 6
DZ - Algeria 5
GR - Grecia 5
GT - Guatemala 5
JO - Giordania 5
RO - Romania 5
TN - Tunisia 5
BY - Bielorussia 4
CL - Cile 4
CR - Costa Rica 4
HN - Honduras 4
NP - Nepal 4
SY - Repubblica araba siriana 4
BB - Barbados 3
BG - Bulgaria 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
AL - Albania 2
CY - Cipro 2
DK - Danimarca 2
KH - Cambogia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
Totale 21.450
Città #
Ashburn 1.059
Fairfield 768
Woodbridge 756
Jacksonville 704
Singapore 700
San Jose 555
Chandler 534
Dallas 484
Houston 468
Ann Arbor 446
Council Bluffs 416
Wilmington 375
Boardman 333
Hong Kong 330
Seattle 327
Cambridge 287
Los Angeles 265
Beijing 261
Nanjing 234
Camerino 202
New York 200
Toronto 182
Warsaw 170
Johannesburg 127
Ho Chi Minh City 123
San Mateo 121
Helsinki 119
Seoul 113
The Dalles 108
Tongling 108
Dearborn 106
Lawrence 100
Princeton 100
Munich 95
Lauterbourg 92
Kraków 91
Istanbul 89
Orem 89
Columbus 85
Dublin 83
Nanchang 82
Ogden 82
Moscow 80
Buffalo 77
Hanoi 75
Santa Clara 75
London 71
Shenyang 69
Lachine 63
Düsseldorf 58
Denver 57
Kunming 56
Shanghai 56
Milan 55
Chicago 53
San Francisco 51
Redwood City 50
Tokyo 49
Frankfurt am Main 44
Tianjin 43
Hebei 42
Brooklyn 41
Brussels 40
Brno 38
Atlanta 37
Phoenix 35
Guangzhou 33
Montreal 32
Rome 32
São Paulo 31
Jiaxing 30
San Diego 30
Trieste 28
Wuhan 28
Changsha 27
Turku 27
Boston 26
Stockholm 26
Augusta 25
Jinan 25
St Louis 25
Bremen 24
Chennai 24
Philadelphia 24
Hangzhou 23
Poplar 23
Centro 22
Da Nang 22
Ascoli Piceno 21
Leawood 21
Ningbo 20
Venezia 19
Zhengzhou 19
Hefei 18
Redondo Beach 17
Venice 17
Auburn Hills 16
Haiphong 16
Nuremberg 16
Rio de Janeiro 16
Totale 14.087
Nome #
Quaternary ammonium surfactants derived from leucine and methionine: Novel challenging surface active molecules with antimicrobial activity 960
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 626
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 335
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 330
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 327
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 302
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 273
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 271
5HT2B receptor antagonists: a probe for spotting the pharmacophore 270
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 267
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 259
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 250
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 244
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 241
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 239
3-[2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl]-5,6,7,8-tetrahydro-4(3H)quinazolinones: serotonin 5-HT2A receptor antagonists endowed with potent, central action 237
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 235
Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process 229
Evaluation of methoxy polyethylene glycol-polylactide diblock copolymers as additive in hypromellose film coating 223
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 222
Dimeric L-Dopa Derivatives as Potential Prodrugs 220
Synthesis and pharmacological evaluation of 4-phenoxy-1,2,3,4-tetrahydroisoquinolines and 4,5,6,6a-tetrahydrochromeno [2,3,4-de]isoquinolines 219
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 219
Synthesis and Evaluation of 2-(5-Methoxythiophen-3- yl)ethylamines as Potential Dopamine Agonists 219
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 219
Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands 217
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 216
Monitoring the aggregation behaviour of self-assembling polymers through high-resolution ultrasonic spectroscopy, 216
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 216
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 216
Synthesis and Preliminary Pharmacological Evaluation of 5-Hydroxy- and 5,6-Dihydroxy-1,2,3,7,12,12a-hexahydrobenzo [5,6]cyclohepta[1,2,3-ij]isoquinoline Derivatives as Dopamine Receptor Ligands 214
New 2- pyridylethylamines with dopaminergic activity: synthesis and radioligand binding evaluation 214
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 213
4-(3-Piridil)-1,2,3,4-tetraidroisochinoline potenziali ligandi dei recettori della dopamina 212
Dopamine D-5 receptors: A challenge to medicinal chemists 212
Novel Imidazoline Compounds as Partial or Full Agonists of D2-Like Dopamine Receptors Inspired by I2-Imidazoline Binding Sites Ligand 2-BFI 211
Synthesis and Pharmacological Characterization of 2-(4-Chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl Derivatives as Dopamine Receptor Ligands 210
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 209
Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-Dopa 206
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 205
Evaluation of polymer mucoadhesiveness by the use of acoustic spectroscopy 205
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 205
Thermosensitive self-assembling block copolymers as drug delivery systems 202
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 200
4WD to Travel Inside the 5-HT1A Receptor World 200
New Systems for the Specific Delivery and Sustained Release of Dopamine to the Brain 199
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 199
Novel Dopamine Receptor Ligands Bearing Imidazoline Nucleus. 195
New L-dopa codrugs as potential antiparkinson agents 194
Evaluation of 2,3,4,8,13a hexahydro-1H-benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 192
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 190
Glycosyl and polyalcoholic prodrugs of lonidamine. 190
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 188
Correlation among chemical structure, surface properties and cytotoxicity of N-acyl alanine and serine surfactants 187
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 184
trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D-1 receptor full agonist 183
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 183
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 181
Activity of N-(2-Phenylethyl)-N-n-Propyl-2-(3-Hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 180
Chemical–physical properties and cytotoxicity of N-decanoyl amino acid-based surfactants: Effect of polar heads 180
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 179
Quaternary Ammonium Leucine-Based Surfactants: The Effect of a Benzyl Group on Physicochemical Properties and Antimicrobial Activity 179
Synthesis, resolution and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptor ligands 178
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 176
Design, synthesis and preliminary pharmacological evaluation of new imidazolinonesas L-DOPA prodrugs 175
A Comparative Behavioural Analysis in Rats of the D2 Agonist RU 24213 and Two New Structurally Similar Compounds 174
DISCOVERY OF NEW POTENTIAL gamma-SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 173
4-Aryloxy-1,2,3,4-tetrahydroisoquinolines as new potential antipsychotic drugs 172
Synthesis and Biological Evaluation of GABA Derivatives Able to Cross the Blood -Brain Barrier in Rats 171
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 171
Receptors in aging diseases: Dopamine receptors 170
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinoles as dopamine receptor ligands 167
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 166
Synthesis and Evaluation of N-n-Propyl-N-(2-phenylethyl)-2-(3-fluoro-4- hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 159
A de novo design probe of a dopamine receptor ligand based on a theoretical approach 157
Imidazolidinoni profarmaci della L-DOPA 156
Polyhydroxylic Prodrugs of Lonidamine 155
Synthesis and SAR of group 11 N-heterocyclic carbene complexes 154
Toxicological profiles and surface properties at physiological pH of N-decanoyl amino acids 151
Preparation and Pharmacological Characterization of trans-2-Amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like Dopamine Receptor Agonists 148
Structure-Activity Relationships of N-n-Propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 145
Synthesis and Dopamine Receptor Binding of 4-(2-Aminoethyl)-1H-pyrazole and Its N,N- Dialkyl Derivatives 143
Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives 141
L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents 138
Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or cognitive and memory performances impaired by scopolamine treatment orlesions of the nucleus basalis of Meynert 134
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma 134
Novel antitumor Cu(I) and Cu(II) complexes based on bioconjugate ligands rationally designed to act through synergistic mechanisms 133
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma 133
Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma 129
Copper complexes with adamantane ring-conjugated ligands as promising agents for the treatment of glioblastoma 129
Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma 127
Investigating the role of the central melanocortin system in stress and stress-related disorders 126
Receptors in aging disease 126
New anticancer copper complexes containing ligands conjugated with biologically active molecules 124
ANTIDEPRESSANT-LIKE ACTIVITY OF NOVEL IMIDAZOLINE LIGANDS DIRECTED TO THE SEROTONIN 5-HT1A RECEPTOR 123
Effect on binge eating episode in female rats of a potent 1 antagonist analogue of spipethiane 122
Copper Complexes with Adamantane Ring- Conjugated Ligands as Promising Agents for the Treatment of Glioblastoma 119
IBUPROFEN AND LIPOIC ACID DIAMIDE AS CO-DRUGS WITH NEUROPROTECTIVE ACTIVITY: PHARMACOLOGICAL PROPERTIES AND EFFECTS IN Βeta-AMYLOID (1-40) INFUSED ALZHEIMER’S DISEASE RAT MODEL 119
Medicinal chemistry and pharmacology of purinergic receptors 117
Trends in drug Research 112
Totale 20.365
Categoria #
all - tutte 81.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.052 83 262 18 51 84 57 35 73 86 117 56 130
2022/20231.484 180 49 75 194 163 201 17 90 264 79 122 50
2023/20241.084 127 61 100 34 39 93 57 36 118 35 24 360
2024/20253.739 167 88 318 165 85 203 453 901 289 237 243 590
2025/20266.549 343 343 693 837 560 423 897 419 333 365 1.110 226
2026/2027223 223 0 0 0 0 0 0 0 0 0 0 0
Totale 21.721